No definition available.
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
519972 |
1. Apply sex-specific ruleNone |
519972 |
2. Check conditionsNone |
519972 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
3 out of 7 registries used, show all original rules. |
1110 |
4. Check minimum number of eventsNone |
1110 |
5. Include endpointsNone |
1110 |
6. Filter based on genotype QC (FinnGen only) |
1070 |
Control definitions (FinnGen only)
- Control exclude
- C3_CANCER, C3_CANCER_WIDE
Extra metadata
- First used in FinnGen datafreeze
- DF12
Similar endpoints
↥List of similar endpoints to
Hepatocellular carcinoma, including Hilmo
based on the number of shared cases.
Similar with more cases:
- Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, including Hilmo
- Malignant neoplasm, wide definition for exclusion
Similar with less cases:
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded (different definition than used in FinnGen).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 1070 | 199 | 871 |
| Unadjusted period prevalence (%) | 0.34 | 0.07 | 0.40 |
| Median age at first event (years) | 72.12 | 72.31 | 72.07 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 1110
- Matched controls
- 11100
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
JN4CD
NOMESCO Finland
Very extensive body CT
42.0
311.9
192
55
C22.0
ICD-10 Finland
Malignant neoplasm: Liver cell carcinoma
+∞
307.7
1078
*
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
13.6
307.7
364
384
8170/3-C22.0
ICD-O-3
Hepatocellular carcinoma, NOS, of liver
+∞
307.7
581
*
D37.6
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Liver, gallbladder and bile ducts
189.8
307.7
377
30
K70.3
ICD-10 Finland
Alcoholic cirrhosis of liver
35.9
307.7
227
79
I85.9
ICD-10 Finland
Oesophageal varices without bleeding
58.2
307.7
189
39
K74.6
ICD-10 Finland
Other and unspecified cirrhosis of liver
55.6
307.7
274
65
130
Kela drug reimbursment
Malignant tumour
+∞
307.7
480
*
JJ2AT
NOMESCO Finland
Biopsy of liver with ultrasound guidance
168.5
307.7
348
30
Z51.5
ICD-10 Finland
Palliative care
29.1
307.7
411
220
N02AA05
ATC
oxycodone; systemic
8.6
276.9
503
971
A03FA01
ATC
metoclopramide; systemic, rectal
10.0
265.6
376
542
R18
ICD-10 Finland
Ascites
30.9
256.5
173
66
198
Kela drug reimbursment
Sorafenib
+∞
235.0
217
*
C22.9
ICD-10 Finland
Malignant neoplasm: Liver, unspecified
+∞
230.5
213
*
JN1CG
NOMESCO Finland
Extensive MRI examination of upper part of abdomen with high intensity magnet
31.9
218.8
145
52
JA3AT
NOMESCO Finland
Cathetrisation of abdominal cavity with ultrasound guidance
34.2
205.7
133
44
JN4AD
NOMESCO Finland
Body CT examination
10.2
195.2
247
302
8000/3-C22.0
ICD-O-3
Neoplasm, malignant of liver
+∞
189.1
176
*
JN1DG
NOMESCO Finland
Very extensive MRI examination of upper part of abdomen with high intensity magnet
30.2
177.2
119
44
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
21.2
174.3
135
72
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
6.4
155.8
322
670
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
14.9
154.7
144
110
WX302
NOMESCO Finland
Thoracal epidural anesthesy
17.2
151.1
129
84
JN4BD
NOMESCO Finland
Extensive body CT
9.5
148.6
192
238
C03DA01
ATC
spironolactone; oral
5.4
148.5
399
1047
JN3CD
NOMESCO Finland
Abdominal CT examination both without and with contrast
14.3
147.9
141
112
A04AA01
ATC
ondansetron; systemic, rectal
19.0
132.4
107
62
L01XE05
ATC
[U] sorafenib
+∞
130.9
123
*
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
8.1
128.9
192
281
H02AB02
ATC
dexamethasone; systemic
19.5
125.7
100
56
C78.7
ICD-10 Finland
Secondary malignant neoplasm of liver and intrahepatic bile duct
+∞
121.1
114
*
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
4.2
119.9
547
2101
323
Kela drug reimbursment
Sorafenib
+∞
118.9
112
*
WD505
NOMESCO Finland
Simple enzyme inhibitor or similar therapy of methastized malignancy
+∞
114.6
108
*
127
Kela drug reimbursment
Transplant complication
24.9
113.4
81
35
JN3AD
NOMESCO Finland
Abdominal CT examination
5.6
109.6
243
528
PC2DT
NOMESCO Finland
Embolisation of lesion of liver
+∞
109.2
103
*
WZC00
NOMESCO Finland
Treatment plan or consultation
4.0
106.7
450
1612
C61
ICD-10 Finland
Malignant neoplasm of prostate
570.4
106.6
104
*
8140/3-C61.9
ICD-O-3
Adenocarcinoma, NOS, of prostate gland
+∞
103.8
98
*
PC2ET
NOMESCO Finland
Extensive embolisation of lesion of liver
+∞
99.5
94
*
L04AA06
ATC
mycophenolic acid; systemic
17.8
94.3
78
47
R93.2
ICD-10 Finland
Abnormal findings on diagnostic imaging of liver and biliary tract
29.0
93.4
63
23
L04AD02
ATC
tacrolimus; systemic
31.1
89.6
59
20
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
+∞
87.7
83
*
C44.31
ICD-10 Finland
Basocellular carcinoma of the skin on another or unspecified part of the face
51.2
84.7
49
10
JN1CD
NOMESCO Finland
Very extensive CT examination of upper part of abdomen
28.6
84.2
57
21
K76.0
ICD-10 Finland
Fatty (change of) liver, not elsewhere classified
12.0
83.9
87
78
A04AA02
ATC
granisetron; systemic, transdermal
871.2
83.7
81
*
K76.9
ICD-10 Finland
Liver disease, unspecified
19.4
83.5
66
36
Z94.4
ICD-10 Finland
Liver transplant status
155.2
82.3
86
6
JA2AT
NOMESCO Finland
Abdominal puncture with ultrasound guidance
28.9
81.5
55
20
A06AD11
ATC
lactulose; oral
3.6
79.5
342
1208
L01EX02
ATC
sorafenib; oral
+∞
79.1
75
*
JJ6LT
NOMESCO Finland
Coagulation of focal hepatic lesion under ultrasound guidance
813.3
78.3
76
*
103
Kela drug reimbursment
Diabetes, insulin-treated
3.1
75.7
551
2659
I85.0
ICD-10 Finland
Oesophageal varices with bleeding
27.2
75.6
52
20
C03CA01
ATC
furosemide; systemic
3.1
73.3
621
3246
WF002
NOMESCO Finland
Radical radiotherapy
95.7
73.0
80
9
XX3DW
NOMESCO Finland
Time consuming IT work
6.5
71.7
125
213
JJC00
NOMESCO Finland
Allogenic transplantation of liver
186.6
67.9
70
*
A10AE04
ATC
insulin glargine; parenteral
3.9
66.4
234
715
3019
Kela drug reimbursment
Lenvatinib
+∞
66.3
63
*
JCA22
NOMESCO Finland
Endoscopic ligature of oesophageal varices
86.8
65.9
73
9
JN1BG
NOMESCO Finland
MRI examination of upper part of abodmen with high intensity magnet
17.9
64.7
53
31
E11.9
ICD-10 Finland
Type 2 diabetes mellitus, without complications
2.9
64.7
493
2390
1508
Kela drug reimbursment
Lenvatinib
+∞
64.2
61
*
A10BA02
ATC
metformin; oral
2.9
63.5
542
2783
C22.1
ICD-10 Finland
Malignant neoplasm: Intrahepatic bile duct carcinoma
+∞
63.1
60
*
WW500
NOMESCO Finland
Blood transfusion
9.5
62.6
76
85
I81
ICD-10 Finland
Portal vein thrombosis
29.1
62.4
42
15
L01EX08
ATC
lenvatinib; oral
+∞
62.1
59
*
K92.0
ICD-10 Finland
Haematemesis
6.9
61.4
99
155
215
Kela drug reimbursment
Diabetes, non-insulin-treated
2.9
61.4
444
2081
JN3BD
NOMESCO Finland
Extensive abdominal CT
4.3
61.0
176
464
A05AA02
ATC
ursodeoxycholic acid; oral
14.9
59.9
54
38
B18.2
ICD-10 Finland
Chronic viral hepatitis C
19.6
59.9
47
25
N02AX02
ATC
tramadol; systemic, rectal
2.7
57.8
594
3307
WZC30
NOMESCO Finland
Teaching
3.7
57.4
212
665
WF049
NOMESCO Finland
Radiotherapy of metastasis
576.0
56.1
55
*
JKE98
NOMESCO Finland
Other transduodenal endoscopic operation on bile duct or ampulla of Vater
12.8
55.9
55
45
T90
ICPC
Diabetes non-insulin dependent
2.7
53.6
432
2112
B01AB10
ATC
tinzaparin; parenteral
4.4
51.8
140
349
TPH07
NOMESCO Finland
Cathetrisation of artery
3.5
51.7
203
660
A10AB05
ATC
insulin aspart; parenteral
3.8
50.8
175
521
116
Kela drug reimbursment
Prostate cancer
+∞
50.4
48
*
JJ9AE
NOMESCO Finland
Ultrasound examination of liver transplant
181.7
50.3
52
*
WX602
NOMESCO Finland
Repeated or continuing anesthesia shots throug a catheter
5.6
49.6
99
191
D77
ICPC
Malignant digestive neopl other/NOS
261.5
49.5
50
*
K83.0
ICD-10 Finland
Cholangitis
9.7
48.7
58
63
A07AA11
ATC
rifaximin; oral
81.1
48.4
54
7
TPH04
NOMESCO Finland
Cathetrisation of vein
2.7
46.6
320
1426
JDW98
NOMESCO Finland
Other transluminal endoscopic operation on stomach or duodenum
11.4
45.3
48
44
PC2SC
NOMESCO Finland
Liver angiography with X-ray
+∞
45.1
43
*
8090/3-C44.9
ICD-O-3
Basal cell carcinoma, NOS, of skin, NOS
+∞
44.0
42
*
L01BC06
ATC
capecitabine; oral
+∞
44.0
42
*
176
Kela drug reimbursment
Regorafenib
+∞
44.0
42
*
JN3DE
NOMESCO Finland
Abdominal extensive ultrasoudn examination with blood flow measurements after transplantation
56.9
41.8
49
9
D37.7
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Other digestive organs
10.6
41.5
46
45
UJF32
NOMESCO Finland
Coloscopy
2.5
41.0
354
1749
L04AD01
ATC
ciclosporin; systemic
10.2
40.3
46
47
R17
ICD-10 Finland
Hyperbilirubinaemia, with or without jaundice, not elsewhere classified
9.9
38.8
45
47
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.3
38.6
594
3741
JJ7LT
NOMESCO Finland
Coagulation of focal hepatic lesion under CT guidance
390.3
38.3
38
*
WX402
NOMESCO Finland
General anaesthesia
2.8
37.7
224
916
D69.6
ICD-10 Finland
Thrombocytopenia, unspecified
7.1
37.2
57
84
K83.1
ICD-10 Finland
Obstruction of bile duct
10.9
36.8
40
38
B01AB04
ATC
dalteparin; parenteral
4.7
36.8
89
202
A10BB12
ATC
glimepiride; oral
3.0
36.1
181
674
J01MA12
ATC
levofloxacin; systemic
2.5
36.1
281
1313
A10BH01
ATC
sitagliptin; oral
2.9
36.0
195
758
C79.5
ICD-10 Finland
Secondary malignant neoplasm of bone and bone marrow
+∞
35.6
34
*
C78.0
ICD-10 Finland
Secondary malignant neoplasm of lung
+∞
35.6
34
*
R4110
NOMESCO Finland
Physiotherapy
2.4
35.4
343
1766
B01AB05
ATC
enoxaparin; parenteral
2.3
35.0
368
1961
A79
ICPC
Malignancy NOS
127.5
34.9
37
*
E11
ICD-10 Finland
Type 2 diabetes mellitus
2.5
34.3
276
1306
K92.1
ICD-10 Finland
Melaena
3.6
34.1
120
359
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
347.4
34.1
34
*
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
78.7
34.0
38
5
WX408
NOMESCO Finland
General anesthesy, balanced
2.4
33.6
292
1429
369
Kela drug reimbursment
Regorafenib
+∞
33.5
32
*
JJB50
NOMESCO Finland
Excision of segments V, VI, VII and VIII of liver
336.7
33.1
33
*
C07AG02
ATC
carvedilol; oral
3.3
32.6
137
459
A49.9
ICD-10 Finland
Bacterial infection, unspecified
2.8
32.4
192
780
A02BC02
ATC
pantoprazole; systemic
2.2
32.3
758
5483
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
63.7
32.2
37
6
JN3KE
NOMESCO Finland
Abdominal ultrasound with added contrast
44.8
32.0
39
9
ZX120
NOMESCO Finland
Intravenous
3.5
31.9
121
380
166
Kela drug reimbursment
Dalteparin and tinzaparin (treatment for more than 6 months)
+∞
31.4
30
*
UJK02
NOMESCO Finland
ERCP
5.7
31.3
60
111
SPAT1262
SPAT
Handing over of treatment supplies
2.4
30.5
276
1368
E11.8
ICD-10 Finland
Type 2 diabetes mellitus, with unspecified complications
2.6
30.4
216
959
L02AE02
ATC
leuprorelin; implant, parenteral
310.5
29.9
30
*
C22
ICD-10 Finland
Malignant neoplasm of liver and intrahepatic bile ducts
+∞
29.3
28
*
JJA44
NOMESCO Finland
Laparoscopic destruction of lesion of liver
+∞
28.2
27
*
8090/3-C44.3
ICD-O-3
Basal cell carcinoma, NOS, of skin of other and unspecified parts of face
+∞
28.2
27
*
R4190
NOMESCO Finland
Nutritional therapy
6.3
28.2
48
79
JJB30
NOMESCO Finland
Excision of two segments of liver
288.5
27.9
28
*
A10AE05
ATC
insulin detemir; parenteral
3.3
27.4
109
352
L01EX05
ATC
regorafenib; oral
+∞
27.2
26
*
WF004
NOMESCO Finland
Palliative radiotherapy
+∞
27.2
26
*
JJB71
NOMESCO Finland
Laparoscopic resection of liver
+∞
27.2
26
*
WD325
NOMESCO Finland
Demanding therapy of methastized malignancy with biomodifiers
+∞
27.2
26
*
C22.7
ICD-10 Finland
Malignant neoplasm: Other specified carcinomas of liver
+∞
27.2
26
*
K72.1
ICD-10 Finland
Chronic hepatic failure
77.1
26.9
30
*
160
Kela drug reimbursment
exenatide
5.6
26.9
52
97
N02AA01
ATC
morphine; systemic, rectal
7.4
26.8
39
54
D97
ICPC
Liver disease NOS
28.6
26.8
36
13
TJA10
NOMESCO Finland
Laparocentesis
143.5
26.7
28
*
R50.9
ICD-10 Finland
Fever, unspecified
2.5
25.7
193
874
ZXE20
NOMESCO Finland
More than three and less than five hours
2.5
25.6
183
810
A10BX07
ATC
[U] liraglutide
7.1
25.6
39
57
J01MA02
ATC
ciprofloxacin; systemic
2.0
25.5
483
3135
JL5SB
NOMESCO Finland
Endoscopic retrograd cholangiopancreaticography
7.3
25.1
37
52
C07AA05
ATC
propranolol; systemic
2.4
24.6
203
959
TK800
NOMESCO Finland
Hemodialysis
5.6
24.5
47
87
346
Kela drug reimbursment
Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)
3.4
24.4
91
282
JJ3AT
NOMESCO Finland
Cytology of liver with ultrasound guidance
+∞
24.0
23
*
JJB10
NOMESCO Finland
Atypcal resection of liver
+∞
24.0
23
*
Z08.0
ICD-10 Finland
Follow-up examination after surgery for malignant neoplasm
245.1
23.7
24
*
A41.5
ICD-10 Finland
Sepsis due to other Gram-negative organisms
4.0
23.2
69
183
ZXE40
NOMESCO Finland
More than seven and less than nine hours
5.5
23.2
45
84
285
Kela drug reimbursment
Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)
3.2
22.9
95
314
A06AH03
ATC
naloxegol; oral
19.4
22.7
34
18
QAE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in head or neck
4.0
22.5
65
169
K70.0
ICD-10 Finland
Alcoholic fatty liver
8.1
22.2
30
38
ZXE30
NOMESCO Finland
More than five and less than seven hours
3.8
22.0
70
195
WD515
NOMESCO Finland
Demanding therapy of malignancy with enzyme inhibitors and similar treatments
+∞
21.9
21
*
C67.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of bladder
+∞
21.9
21
*
JN3GE
NOMESCO Finland
Intraoperative ultrasound examination of abdomen
+∞
21.9
21
*
A10AC01
ATC
insulin (human); parenteral
2.5
21.8
145
619
XJA00
NOMESCO Finland
Intraoperative abdominal ultrasonography
224.2
21.7
22
*
D50.9
ICD-10 Finland
Iron deficiency anaemia, unspecified
2.8
21.0
111
421
WD405
NOMESCO Finland
Simple antiboidy therapy of methastized malignancy
61.2
20.9
24
*
D64.9
ICD-10 Finland
Anaemia, unspecified
2.3
20.9
173
814
C64.88
ICD-10 Finland
Other malignant neoplasm of kidney, except renal pelvis
+∞
20.9
20
*
JJA43
NOMESCO Finland
Destruction of lesion of liver
+∞
20.9
20
*
8160/3-C22.1
ICD-O-3
Cholangiocarcinoma of intrahepatic bile duct
+∞
20.9
20
*
C24.9
ICD-10 Finland
Malignant neoplasm: Biliary tract, unspecified
+∞
20.9
20
*
UJF30
NOMESCO Finland
Ileoscopy through colon
2.7
20.7
121
484
JJ5AT, ,
NOMESCO Finland
213.8
20.6
21
*
JJA20
NOMESCO Finland
Open biopsy of liver
112.2
20.6
22
*
D13.4
ICD-10 Finland
Benign neoplasm: Liver
33.2
20.2
26
8
WPA10
NOMESCO Finland
Proactive palliative care treatment plan
36.5
19.9
25
7
A10BH05
ATC
linagliptin; oral
2.9
19.8
100
370
E11.7
ICD-10 Finland
Type 2 diabetes mellitus, with multiple complications
2.5
19.7
130
551
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
2.0
19.7
252
1406
E66.00
ICD-10 Finland
Metabolic syndrome
3.1
19.4
85
290
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
2.1
19.3
209
1095
8000/3-C80.9
ICD-O-3
Neoplasm, malignant of unknown primary site
+∞
18.8
18
*
L02BB03
ATC
bicalutamide; oral
+∞
18.8
18
*
L01XE21
ATC
[U] regorafenib
+∞
18.8
18
*
WD115
NOMESCO Finland
Multiple cystostatic therapy of methastized malignancy
101.8
18.6
20
*
A10BG03
ATC
pioglitazone; oral
3.7
18.6
59
164
JKE18
NOMESCO Finland
Endoscopic internal drainage of bile duct
17.9
18.3
28
16
A41.8
ICD-10 Finland
Other specified sepsis
4.6
18.1
43
96
205
Kela drug reimbursment
Chronic hypertension
1.8
18.1
433
2940
RS220, ,
NOMESCO Finland
7.4
17.9
26
36
XX4BW, ,
NOMESCO Finland
67.7
17.8
20
*
XZZ00
NOMESCO Finland
Active surveillance of a diagnosed cancer
+∞
17.8
17
*
C78.6
ICD-10 Finland
Secondary malignant neoplasm of retroperitoneum and peritoneum
+∞
17.8
17
*
K29.6
ICD-10 Finland
Other gastritis
6.3
17.7
30
49
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
2.8
17.5
91
342
K70.1
ICD-10 Finland
Alcoholic hepatitis
7.9
17.5
24
31
KCD02
NOMESCO Finland
Transurethral resection of bladder
14.1
17.3
29
21
ZXM00
NOMESCO Finland
Intraoperative use of ultrasonographic imaging
15.1
17.2
28
19
A10BX04
ATC
[U] exenatide
6.7
17.1
27
41
JK3BT
NOMESCO Finland
Catherisation of bile duct with X-ray guidance
32.0
17.1
22
7
162
Kela drug reimbursment
liraglutide
5.8
16.9
31
55
K92.2
ICD-10 Finland
Gastrointestinal haemorrhage, unspecified
3.7
16.8
55
156
ZXD10
NOMESCO Finland
Scheduled procedure
1.8
16.8
401
2709
8120/3-C67.9
ICD-O-3
Transitional cell carcinoma, NOS, of bladder, NOS
+∞
16.7
16
*
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
2.2
16.7
147
708
Z2221
NOMESCO Finland
Medical doctor
1.9
16.7
268
1606
ZXE00
NOMESCO Finland
One hour or less
1.7
16.4
389
2617
JKA20
NOMESCO Finland
Cholecystectomy
3.6
16.4
55
159
JKE25
NOMESCO Finland
Endoscopic external drainage of bile duct
40.7
16.4
20
5
ZXE03
NOMESCO Finland
Procedure duration 20 to 29 minutes
3.1
16.3
69
231
XF603
NOMESCO Finland
Direct intraarterial blood pressure measurement
3.9
16.1
47
123
JAH00
NOMESCO Finland
Laparotomy
4.2
15.9
42
102
WX404
NOMESCO Finland
Intravenous generell anesthesy
2.1
15.7
168
872
C20.91
ICD-10 Finland
Malignant tumor of the rectum invasive carcinoma
+∞
15.7
15
*
KEC01
NOMESCO Finland
Percutaneous endoscopic radical prostatectomy
+∞
15.7
15
*
C18.70
ICD-10 Finland
Malignant tumor of the sigmoid without histology
+∞
15.7
15
*
Y77
ICPC
Malignant neoplasm prostate
86.3
15.6
17
*
C67.9
ICD-10 Finland
Malignant neoplasm: Bladder, unspecified
162.2
15.5
16
*
Z3231
NOMESCO Finland
Registered nurse
1.8
15.4
287
1795
WVA20
NOMESCO Finland
Medicine administration
4.4
15.3
38
88
Z2446
NOMESCO Finland
Social worker
2.8
15.2
79
297
XX2RW, ,
NOMESCO Finland
20.4
15.1
22
11
WD305
NOMESCO Finland
Simple therapy of methastized malignancy with biomodifiers
+∞
14.6
14
*
E66.01
ICD-10 Finland
Obesity due to excess calories
2.7
14.6
79
303
ZX050
NOMESCO Finland
Stereotactic radiotherapy
81.2
14.6
16
*
TJA40
NOMESCO Finland
Percutaneous local drainage of peritoneal cavity
151.9
14.5
15
*
A10BD07
ATC
metformin and sitagliptin; systemic
2.8
14.4
76
288
N05CF01
ATC
zopiclone; oral
1.7
14.4
363
2468
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.7
14.0
326
2163
E11.6
ICD-10 Finland
Type 2 diabetes mellitus, with other specified complications
3.6
14.0
47
136
A10BJ02
ATC
liraglutide; parenteral
3.7
13.9
44
122
N17.9
ICD-10 Finland
Acute renal failure, unspecified
2.7
13.9
75
287
SPAT1250
SPAT
Comprehensive monitoring of chronic illness
1.7
13.9
345
2330
XCK10
NOMESCO Finland
Photography of fundus of eye
2.2
13.9
132
654
PC1BC
NOMESCO Finland
Extensive angiography of aorta and abdominal arteries
17.8
13.9
21
12
A10BB01
ATC
glibenclamide; oral
2.4
13.7
99
437
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
2.1
13.6
131
652
WB113
NOMESCO Finland
Multiple adjuvant cytostatic therapy
+∞
13.6
13
*
YJ1AD
NOMESCO Finland
CT examination of abdomen for dose design of radiotherapy
+∞
13.6
13
*
115
Kela drug reimbursment
Breast cancer
+∞
13.6
13
*
YL1BD
NOMESCO Finland
Extensive CT examination of pelvis for dose design of radiotherapy
+∞
13.6
13
*
WX002
NOMESCO Finland
Sedation and analgesia
1.9
13.5
213
1260
PJA12
NOMESCO Finland
Sentinel node biopsy
141.7
13.5
14
*
YL1AD
NOMESCO Finland
CT examination of pelvis for dose design of radiotherapy
141.7
13.5
14
*
J01FF01
ATC
clindamycin; systemic
1.7
13.4
286
1849
K70.4
ICD-10 Finland
Alcoholic hepatic failure
14.0
13.3
22
16
JAH01
NOMESCO Finland
Laparoscopy
4.2
13.1
35
86
XW000
NOMESCO Finland
Bone marrow biopsy
3.3
13.0
48
148
K70.9
ICD-10 Finland
Alcoholic liver disease, unspecified
12.4
12.6
22
18
WPB10
NOMESCO Finland
Making a convalescent care decision
32.4
12.6
16
5
ZX090
NOMESCO Finland
Other technic of radiotherapy
32.4
12.6
16
5
JJB20
NOMESCO Finland
Excision of single segment of liver
+∞
12.5
12
*
8140/3-C20.9
ICD-O-3
Adenocarcinoma, NOS, of rectum, NOS
+∞
12.5
12
*
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
+∞
12.5
12
*
1550A
ICD-9 Finland
Malignant neoplasm of liver and intrahepatic bile ducts, Liver, primary
+∞
12.5
12
*
L01XE29
ATC
[U] lenvatinib
+∞
12.5
12
*
K72.9
ICD-10 Finland
Hepatic failure, unspecified
9.4
12.5
25
27
K72.0
ICD-10 Finland
Acute and subacute hepatic failure
13.4
12.5
21
16
WW200, ,
SPAT
0.4
12.4
75
1635
JL5BG
NOMESCO Finland
MRI examinaiton of bile and pancreas ducts with high intesity magnet
3.8
12.3
37
99
JK3NB
NOMESCO Finland
Percutaneous transhepatic cholangiography
38.0
12.2
15
*
K76.7
ICD-10 Finland
Hepatorenal syndrome
21.6
12.0
17
8
L03AA13
ATC
pegfilgrastim; parenteral
47.2
11.9
14
*
JJ1LE
NOMESCO Finland
Ultrasound elastography of liver
10.7
11.8
22
21
JL5AG
NOMESCO Finland
Simple MRI examinaiton of bile and pancreas ducts with high intesity magnet
10.7
11.8
22
21
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
2.2
11.7
105
507
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
2.7
11.7
65
253
WX892
NOMESCO Finland
Monitored bed care
2.2
11.6
101
482
K76.89
ICD-10 Finland
Other specified diseases of liver
23.2
11.6
16
7
WZC10
NOMESCO Finland
Written specialist consultation based on a referral from a dentist or a physician
2.9
11.6
55
197
JK3FT
NOMESCO Finland
Exchange of bile duct catheter with radiological guidance
+∞
11.5
11
*
C18.71
ICD-10 Finland
Malignant tumor of the sigmoid invasive carcinoma
+∞
11.5
11
*
JKD20
NOMESCO Finland
Anastomosis of bile duct to jejunum
+∞
11.5
11
*
JN1AD
NOMESCO Finland
CT examination of upper part of abdomen
15.2
11.3
18
12
ZX108
NOMESCO Finland
Inhalation
10.7
11.3
21
20
JN3CG
NOMESCO Finland
Extensive MRI examination of abdomen with high intensity magnet
35.4
11.3
14
*
ZXE10
NOMESCO Finland
More than one and less than three hours
1.6
11.1
351
2493
I10
ICD-10 Finland
Essential (primary) hypertension
1.6
11.1
735
6162
JL5CG
NOMESCO Finland
Extensive MRI examinaiton of bile and pancreas ducts with high intesity magnet
9.3
11.0
22
24
A10BJ06
ATC
semaglutide; parenteral
2.7
11.0
59
226
N06DX01
ATC
memantine; oral
0.3
10.9
22
828
D50.0
ICD-10 Finland
Iron deficiency anaemia secondary to blood loss (chronic)
2.9
10.9
52
187
NK6QA
NOMESCO Finland
Measurement of bone density from two or more locations with X-ray
2.9
10.9
50
176
D41.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Kidney
4.5
10.8
26
59
Z3226
NOMESCO Finland
Physiotherapist
1.8
10.7
187
1135
L04AX01
ATC
azathioprine; systemic
3.0
10.6
47
162
JN1BD
NOMESCO Finland
Extensive CT examination of upper part of abdomen
10.2
10.5
20
20
D12.6
ICD-10 Finland
Benign neoplasm: Colon, unspecified
2.4
10.5
74
323
ZZA00
NOMESCO Finland
Split skin graft
3.5
10.5
36
106
EBA15
NOMESCO Finland
Extraction of multiple teeth
2.7
10.5
56
214
KE3AT
NOMESCO Finland
Transrectal gold marker implantation in prostate under ultrasound guidance
111.0
10.4
11
*
YG1BD
NOMESCO Finland
Extensive CT examination of thorax for dose design of radiotherapy
111.0
10.4
11
*
C50.41
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor
+∞
10.4
10
*
WF003
NOMESCO Finland
Adjuvant radiotherapy
+∞
10.4
10
*
JJB40
NOMESCO Finland
Excision of segments II, III and IV of liver
+∞
10.4
10
*
C67.2
ICD-10 Finland
Malignant neoplasm: Lateral wall of bladder
+∞
10.4
10
*
YG1AD
NOMESCO Finland
CT examination of thorax for dose design of radiotherapy
+∞
10.4
10
*
C22.2
ICD-10 Finland
Malignant neoplasm: Hepatoblastoma
+∞
10.4
10
*
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
2.6
10.4
60
238
177
Kela drug reimbursment
Insulin glargine 300 U / ml
4.0
10.3
29
74
H02AB04
ATC
methylprednisolone; systemic
1.9
10.3
152
876
G93.4
ICD-10 Finland
Encephalopathy, unspecified
10.7
10.3
19
18
K73.2
ICD-10 Finland
Chronic active hepatitis, not elsewhere classified
19.0
10.3
15
8
QBE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin of trunk
2.9
10.2
47
166
KE1AT
NOMESCO Finland
Biopsy of prostata with ultrasoudnguidance
3.0
10.1
44
150
WX000
NOMESCO Finland
Monitoring vital functions without anesthesy
2.8
10.1
49
178
M04AA01
ATC
allopurinol; systemic
1.7
10.1
205
1299
SPAT1109
SPAT
Analgesia with portable analgesic pump
14.7
10.0
16
11
ZXE50
NOMESCO Finland
More than nine and less than 12 hours
4.1
10.0
27
67
F10.1
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Harmful use
2.1
10.0
95
470
UJF45
NOMESCO Finland
Flexible sigmoidoscopy with biopsy
2.3
10.0
75
337
K73.0
ICD-10 Finland
Chronic persistent hepatitis, not elsewhere classified
40.4
10.0
12
*
308
Kela drug reimbursment
Alprostadil, sildenafil and combination product containing aviptadil and phentolamine
40.4
10.0
12
*
L03AA02
ATC
filgrastim; parenteral
26.3
9.8
13
5
UJK12
NOMESCO Finland
Peroral cholangioscopy
26.3
9.8
13
5
L04AA10
ATC
[U] sirolimus
55.5
9.7
11
*
R10.1
ICD-10 Finland
Pain localized to upper abdomen
1.8
9.6
157
934
ZXD05
NOMESCO Finland
Urgent procedure
1.6
9.6
312
2219
A41.9
ICD-10 Finland
Sepsis, unspecified
2.6
9.6
55
218
C20.90
ICD-10 Finland
Malignant tumor of the rectum without histology
100.9
9.4
10
*
L04AA18
ATC
[U] everolimus
100.9
9.4
10
*
JK4ZT
NOMESCO Finland
Percutaneous transhepatic implantation of bile duct prothesis
100.9
9.4
10
*
PC2DE
NOMESCO Finland
Ultrasound examination of liver vasculature with Doppler method
100.9
9.4
10
*
I86.4
ICD-10 Finland
Gastric varices
30.3
9.4
12
*
ZX080
NOMESCO Finland
Image guided radiotherapy
+∞
9.4
9
*
C25.0
ICD-10 Finland
Malignant neoplasm: Head of pancreas
+∞
9.4
9
*
C24.00
ICD-10 Finland
Hepatic duct
+∞
9.4
9
*
8310/3-C64.9
ICD-O-3
Clear cell adenocarcinoma, NOS, of kidney, NOS
+∞
9.4
9
*
C77.2
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Intra-abdominal lymph nodes
+∞
9.4
9
*
8090/3-C44.5
ICD-O-3
Basal cell carcinoma, NOS, of skin of trunk
+∞
9.4
9
*
E11.3
ICD-10 Finland
Type 2 diabetes mellitus, with ophthalmic complications
2.6
9.3
52
204
C10AA05
ATC
atorvastatin; oral
0.6
9.2
303
4074
UJD02
NOMESCO Finland
Gastroscopy
2.3
9.2
66
291
R10.0
ICD-10 Finland
Acute abdomen
3.2
9.1
36
116
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
2.2
9.1
79
377
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
3.8
9.1
27
72
JN5DR
NOMESCO Finland
PET-CT of upper body metabolism
15.7
9.0
14
9
XW4AT
NOMESCO Finland
Biopsy of other inner organ with ultrasound guidance
37.0
9.0
11
*
J90
ICD-10 Finland
Pleural effusion, not elsewhere classified
2.7
9.0
46
172
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
1.6
8.8
272
1905
A28
ICPC
Limited function/disability NOS
1.6
8.8
228
1532
V03AE01
ATC
polystyrene sulfonate; oral
4.1
8.8
24
60
IAZ97
NOMESCO Finland
Psychiatric consultation in another specialty
8.7
8.8
18
21
K29.3
ICD-10 Finland
Chronic superficial gastritis
2.7
8.8
47
180
C10AX09
ATC
ezetimibe; oral
0.5
8.7
67
1348
601
Kela drug reimbursment
Severe malabsorption of nutrients, mainly fats
14.2
8.7
14
10
YX9AD
NOMESCO Finland
Other CT eamination for dose design of radiotherapy
50.4
8.7
10
*
E0000UV, ,
ATC
1.5
8.7
363
2716
ZXE04
NOMESCO Finland
Procedure duration 30 to 39 minutes
2.4
8.6
57
242
C44.51
ICD-10 Finland
Basocellular carcinoma of the skin on the torso
11.7
8.6
15
13
B02AA02
ATC
tranexamic acid; systemic
2.1
8.5
78
381
HAB40
NOMESCO Finland
Wedge excision of mammary gland
27.7
8.5
11
*
AA1BD
NOMESCO Finland
Extensive CT of head and brain
3.9
8.4
24
62
Z51.1
ICD-10 Finland
Chemotherapy session for neoplasm
90.7
8.4
9
*
WPA43, ,
SPAT
90.7
8.4
9
*
K29.7
ICD-10 Finland
Gastritis, unspecified
2.6
8.4
47
184
L40.0
ICD-10 Finland
Psoriasis vulgaris
2.5
8.4
50
202
PG1DE
NOMESCO Finland
Other extensive ultrasound examination of artery
2.4
8.4
57
245
K73.9
ICD-10 Finland
Chronic hepatitis, unspecified
12.9
8.4
14
11
R74.0
ICD-10 Finland
Elevation of levels of transaminase and lactic acid dehydrogenase [LDH]
3.8
8.4
25
67
ZX020
NOMESCO Finland
HDR radiotherapy within tissue
+∞
8.3
8
*
C18.21
ICD-10 Finland
Malignant tumor of the ascending colon invasive carcinoma
+∞
8.3
8
*
C24.09
ICD-10 Finland
Biliary duct or passage NOS
+∞
8.3
8
*
OAB38
NOMESCO Finland
Psychosocial guidance and counselling
+∞
8.3
8
*
YJ1BD
NOMESCO Finland
Extensive CT examination of abdomen for dose design of radiotherapy
+∞
8.3
8
*
JJB60
NOMESCO Finland
Other excsion of three or more segments of liver
+∞
8.3
8
*
J01DB01
ATC
cefalexin; oral
1.5
8.3
787
6876
ZXC40
NOMESCO Finland
Use of ultrasound
10.8
8.3
15
14
K51.5
ICD-10 Finland
Left sided colitis
3.3
8.2
30
92
K74.0
ICD-10 Finland
Hepatic fibrosis
14.6
8.2
13
9
D13.1
ICD-10 Finland
Benign neoplasm: Stomach
3.6
8.2
26
73
JFA15
NOMESCO Finland
Endoscopic polypectomy in colon
2.1
8.1
72
347
A10BG02
ATC
rosiglitazone; oral
3.4
8.1
29
88
WD415
NOMESCO Finland
Demanding antibody therapy of methastized malignancy
33.6
8.1
10
*
XF612
NOMESCO Finland
Measurement of central venous pressure
33.6
8.1
10
*
D48.5
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Skin
2.6
8.1
47
188
E11.00
ICD-10 Finland
Non-insulin dependent diabetes diabetic hypoglycaemic coma
2.2
8.1
66
308
A46
ICD-10 Finland
Erysipelas
1.6
8.0
181
1174
XF400
NOMESCO Finland
ECG with 12 standard connections
1.6
8.0
206
1380
WZB00
NOMESCO Finland
Telephone prescription or other care instructions
1.6
8.0
224
1531
E11.4
ICD-10 Finland
Type 2 diabetes mellitus, with neurological complications
2.6
8.0
45
177
T81.0
ICD-10 Finland
Haemorrhage and haematoma complicating a procedure, not elsewhere classified
2.3
8.0
62
283
C10AA07
ATC
rosuvastatin; oral
0.6
7.9
172
2555
G30.9
ICD-10 Finland
Alzheimer disease, unspecified
0.2
7.9
7
365
K75.0
ICD-10 Finland
Abscess of liver
13.1
7.9
13
10
PG1PT
NOMESCO Finland
Extensive endovascular embolisation for bleeding with radiological guidance not elsewhere classified
9.5
7.8
15
16
JFA98
NOMESCO Finland
Other transluminal endoscopic local operation on intestine
3.7
7.8
24
66
JKE22
NOMESCO Finland
Endoscopic extraction of foreign body from bile duct
15.1
7.7
12
8
C44.32
ICD-10 Finland
Spinocellular carcinoma of the skin on another or unspecified part of the face
45.3
7.7
9
*
A98
ICPC
Health maint/preventive medicine
0.7
7.7
779
8620
H02AB06
ATC
prednisolone; systemic
1.4
7.7
466
3726
WX882
NOMESCO Finland
High dependency care
2.9
7.6
35
124
XJD02
NOMESCO Finland
Peroral endoscopic ultrasonography
8.9
7.6
15
17
TPX10
NOMESCO Finland
Implantation of vascular injection port
3.3
7.6
27
82
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
2.0
7.4
77
394
ZX070
NOMESCO Finland
Intensity modified radiotherapy
80.6
7.4
8
*
8500/3-C50.9
ICD-O-3
Infiltrating duct carcinoma, NOS, of breast, NOS
80.6
7.4
8
*
C44.41
ICD-10 Finland
Basocellular carcinoma of the skin of the scalp and neck
80.6
7.4
8
*
I85
ICD-10 Finland
Oesophageal varices
80.6
7.4
8
*
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
2.8
7.4
37
137
A04AA55
ATC
palonosetron, combinations; systemic
+∞
7.3
7
*
WD135
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
+∞
7.3
7
*
6603
FHL
Delete a block
+∞
7.3
7
*
L02AE04
ATC
triptorelin; parenteral
+∞
7.3
7
*
C18.20
ICD-10 Finland
Malignant tumor of the ascending colon without histology
+∞
7.3
7
*
K74
ICD-10 Finland
Fibrosis and cirrhosis of liver
+∞
7.3
7
*
L04AH02
ATC
everolimus; oral
+∞
7.3
7
*
C78.8
ICD-10 Finland
Secondary malignant neoplasm of other and unspecified digestive organs
+∞
7.3
7
*
C23
ICD-10 Finland
Malignant neoplasm of gallbladder
+∞
7.3
7
*
8160/3-C24.9
ICD-O-3
Cholangiocarcinoma of billiary tract, NOS
+∞
7.3
7
*
8070/3-C44.9
ICD-O-3
Squamous cell carcinoma, NOS, of skin, NOS
+∞
7.3
7
*
Z94.9
ICD-10 Finland
Transplanted organ and tissue status, unspecified
+∞
7.3
7
*
C24.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of biliary tract
+∞
7.3
7
*
KEC00
NOMESCO Finland
Retropubic radical prostatectomy
+∞
7.3
7
*
WPA13
NOMESCO Finland
Palliative consultation
15.9
7.2
11
7
NK6AN
NOMESCO Finland
Total body bone isotope imaging
15.9
7.2
11
7
A10BD03
ATC
metformin and rosiglitazone; systemic
3.1
7.2
30
100
K03.82
ICD-10 Finland
Split tooth for reasons other than trauma
0.5
7.2
77
1389
N02AA03
ATC
hydromorphone; systemic, rectal
30.2
7.2
9
*
G30.1
ICD-10 Finland
Alzheimer disease with late onset
0.3
7.1
22
657
D37.9
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Digestive organ, unspecified
20.2
7.1
10
5
T31
ICPC
Metabolic, Medical examin/health eval partial
6.1
7.1
18
30
GD1CT
NOMESCO Finland
Biopsy of the lung with CT guidance
12.1
7.1
12
10
TPH30
NOMESCO Finland
Insertion of central venous catheter through periferal vein
3.7
7.0
22
61
C10AC01
ATC
colestyramine; oral
3.1
7.0
28
91
A07AA09
ATC
vancomycin; oral
3.9
7.0
20
52
A10BH02
ATC
vildagliptin; oral
2.9
7.0
32
113
L02.4
ICD-10 Finland
Cutaneous abscess, furuncle and carbuncle of limb
2.7
7.0
36
136
D02AX
ATC
Other emollients and protectives
3.1
6.9
28
92
RD210, ,
NOMESCO Finland
4.0
6.9
19
48
T48
ICPC
Metabolic, Clarification/discussion RFE/demand
13.9
6.9
11
8
KCD05
NOMESCO Finland
Excision of bladder lesion during urinary tract endoscopy with photodynamic diagnosis (PDD)
13.9
6.9
11
8
Z04.8
ICD-10 Finland
Examination and observation for other specified reasons
1.8
6.9
110
649
N06DA02
ATC
donepezil; oral
0.3
6.9
21
630
R60.0
ICD-10 Finland
Localized oedema
1.7
6.9
129
797
SPAT1255
SPAT
Intravenous administration of medicine
2.0
6.9
78
413
M01AB01
ATC
indometacin; systemic, rectal
1.7
6.8
116
697
D69.5
ICD-10 Finland
Secondary thrombocytopenia
40.3
6.8
8
*
JCA20
NOMESCO Finland
Ligature of oesophageal varices
40.3
6.8
8
*
WZC15, ,
NOMESCO Finland
40.3
6.8
8
*
C44.61
ICD-10 Finland
Basocellular carcinoma of the skin of the upper extremity including the shoulder
40.3
6.8
8
*
H01CB02
ATC
octreotide; parenteral
40.3
6.8
8
*
JJ1AT
NOMESCO Finland
Puncture of lesion of liver with ultrasound guidance
40.3
6.8
8
*
T45
ICPC
Metabolic, Observ/health educat/advice/diet
3.2
6.7
26
83
E14.9
ICD-10 Finland
Unspecified diabetes mellitus, without complications
3.3
6.7
24
73
D05AX52
ATC
calcipotriol, combinations; topical
2.2
6.7
56
264
D05AX02
ATC
calcipotriol; topical
2.3
6.7
47
206
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
1.5
6.7
228
1625
UKC02
NOMESCO Finland
Cystoscopy
1.6
6.6
186
1269
Y83
ICD-10 Finland
Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
2.0
6.6
74
390
EB1CI
NOMESCO Finland
Cone beam imaging of teeth and jaws (3-4 quarters)
6.9
6.5
15
22
K29.5
ICD-10 Finland
Chronic gastritis, unspecified
2.6
6.5
36
141
K40.9
ICD-10 Finland
Unilateral or unspecified inguinal hernia, without obstruction or gangrene
0.5
6.5
82
1410
XX1XW
NOMESCO Finland
Extensive written report from radiologist
3.3
6.4
23
70
HAC20
NOMESCO Finland
Total mastectomy
70.2
6.4
7
*
JK3NT
NOMESCO Finland
Percutaneous transhepatic dilatation of bileducts
70.2
6.4
7
*
JX1XE
NOMESCO Finland
Other ultrasound examinaton of alimentary organs
70.2
6.4
7
*
ZZR00
NOMESCO Finland
Flap of skin
7.4
6.4
14
19
P15
ICPC
Chronic alcohol abuse
2.5
6.4
38
154
K70.2
ICD-10 Finland
Alcoholic fibrosis and sclerosis of liver
14.4
6.4
10
7
A10BJ01
ATC
exenatide; parenteral
4.1
6.4
17
42
208
Kela drug reimbursment
Ulcerative colitis and Crohn's disease
2.4
6.4
41
173
E13.9
ICD-10 Finland
Other specified diabetes mellitus, without complications
6.6
6.3
15
23
EBA10
NOMESCO Finland
Operative extraction of tooth
1.9
6.3
80
439
A10BB07
ATC
glipizide; oral
2.8
6.3
31
114
K73.80
ICD-10 Finland
Non-alcoholic fatty liver (NASH, Non Alcoholic Steatohepatitis)
11.1
6.3
11
10
JKE32
NOMESCO Finland
Endoscopic dilatation of bile duct
11.1
6.3
11
10
TJJ00
NOMESCO Finland
Percutaneous needle biopsy of liver
11.1
6.3
11
10
E83.1
ICD-10 Finland
Disorders of iron metabolism
9.3
6.3
12
13
377
Kela drug reimbursment
Apremilast and dimethyl fumarate (psoriasis)
18.1
6.3
9
5
WB203
NOMESCO Finland
Simple adjuvant hormone therapy of malignancy
+∞
6.3
6
*
8140/3-C18.0
ICD-O-3
Adenocarcinoma, NOS, of cecum
+∞
6.3
6
*
GDC01
NOMESCO Finland
Thoracoscopic lobectomy of lung
+∞
6.3
6
*
C67.0
ICD-10 Finland
Malignant neoplasm: Trigone of bladder
+∞
6.3
6
*
SPAT1122
SPAT
Ascites puncture
+∞
6.3
6
*
C34.12
ICD-10 Finland
Malignant tumor of the anterior, bronchial or pulmonary adenocarcinoma
+∞
6.3
6
*
8140/3-C18.7
ICD-O-3
Adenocarcinoma, NOS, of sigmoid colon
+∞
6.3
6
*
C20
ICD-10 Finland
Malignant neoplasm of rectum
+∞
6.3
6
*
8140/3-C18.9
ICD-O-3
Adenocarcinoma, NOS, of colon, NOS
+∞
6.3
6
*
C64
ICD-10 Finland
Malignant neoplasm of kidney, except renal pelvis
+∞
6.3
6
*
C43.50
ICD-10 Finland
Malignant melanoma of the torso without histology
+∞
6.3
6
*
K76.6
ICD-10 Finland
Portal hypertension
26.8
6.2
8
*
WPA11
NOMESCO Finland
Developing a plan for palliative care
26.8
6.2
8
*
K74.5
ICD-10 Finland
Biliary cirrhosis, unspecified
26.8
6.2
8
*
D38.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Trachea, bronchus and lung
3.7
6.2
19
52
C09BA02
ATC
enalapril and diuretics; systemic
1.7
6.2
109
661
K75.9
ICD-10 Finland
Inflammatory liver disease, unspecified
4.0
6.2
17
43
A02BD07
ATC
lansoprazole, amoxicillin and clarithromycin; systemic
2.1
6.2
53
253
N03AX16
ATC
[U] pregabalin
1.5
6.2
205
1450
J94.8
ICD-10 Finland
Other specified pleural conditions
3.2
6.2
23
72
E66.8
ICD-10 Finland
Other obesity
2.5
6.2
36
145
K74.3
ICD-10 Finland
Primary biliary cirrhosis
7.7
6.1
13
17
D02AE01
ATC
carbamide; topical
2.0
6.1
63
323
OAB73
NOMESCO Finland
Prevention and treatment of malnutrition
8.7
6.1
12
14
D07AC01
ATC
betamethasone; topical
1.4
6.1
338
2637
PC1CC
NOMESCO Finland
Very extensive angiography of aorta and abdominal arteries
10.1
6.0
11
11
UJF92
NOMESCO Finland
Capsular endoscopy
3.4
6.0
21
63
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
281
186
19.89
307.65
1.5
1.1
59.50
82.31
titre
0.47
20
13
415
141
46.41
307.65
3.9
1.8
195.61
49.59
u/ml
0.66
370
110
221
83
33.00
307.65
2.4
1.7
77.00
25.76
u/ml
1.23
210
73
323
204
21.92
307.65
5.2
2.2
44.58
34.66
umol/l
4.21
307
182
528
626
15.18
307.65
5.8
1.9
0.17
0.19
g/l
7.17
500
552
598
405
30.84
307.65
4.0
1.3
4.44
2.77
ug/l
1.29
509
300
212
97
26.78
295.13
1.4
1.1
1.63
1.57
g/l
0.56
204
85
463
792
9.31
284.91
11.4
2.4
18.01
10.22
umol/l
3.02
441
686
380
800
6.70
184.23
11.9
6.2
8.77
11.42
mmol/l
7.65
366
748
116
55
23.44
157.22
1.5
1.2
—
—
—
0
0
235
385
7.47
143.18
1.7
1.3
1.59
1.18
g/l
2.37
215
344
765
3420
4.98
142.39
16.1
3.7
31.88
35.05
g/l
38.71
743
3106
612
2316
4.66
142.27
12.8
2.6
63.58
35.29
u/l
8.87
597
2180
542
1892
4.64
139.76
16.3
3.6
72.88
81.06
%
11.54
531
1830
327
775
5.56
135.73
2.5
1.7
1.67
1.66
%
0.08
289
645
801
3895
4.80
128.38
23.9
3.8
23.70
13.09
umol/l
12.65
786
3654
249
488
6.29
126.47
2.1
1.9
13.83
11.27
g/l
10.44
232
440
82
27
32.71
126.14
2.3
2.3
791.31
422.50
e6/l
0.67
59
20
144
153
10.67
124.54
1.3
1.3
—
—
—
0
0
75
22
36.49
119.26
2.2
1.9
1436.43
92790.17
e6/l
0.51
46
12
382
1153
4.53
116.08
2.7
2.5
25.45
22.73
%
1.99
347
966
381
1214
4.26
106.53
4.7
2.7
0.76
0.82
mmol/l
16.69
365
1106
382
1230
4.21
105.10
2.7
2.4
2.34
2.24
g/l
2.30
361
1126
86
61
15.20
95.56
1.3
1.3
180.91
207.50
titre
0.06
11
12
386
1329
3.92
95.37
2.8
2.4
13.74
12.64
umol/l
1.76
369
1215
300
875
4.33
93.27
3.3
2.5
242.62
237.29
u/l
0.26
294
803
555
2472
3.49
91.45
5.5
2.2
61.30
61.38
u/l
0.01
540
2260
133
197
7.53
87.37
5.1
3.0
1.67
1.65
mg/l
0.06
124
171
243
636
4.61
86.55
4.3
2.1
31.44
32.59
u/l
0.22
216
511
56
19
30.99
84.93
1.8
1.2
9.43
12.09
g/l
0.63
39
11
772
4361
3.53
83.47
23.6
20.1
1.32
1.44
inr
2.88
209
1234
90
98
9.91
75.79
1.3
1.4
112.43
109.20
u/ml
—
7
14
421
1741
3.28
75.44
4.1
2.1
—
—
—
0
0
359
1390
3.34
71.14
2.8
1.9
32.42
30.22
s
5.98
354
1344
70
59
12.60
70.06
1.0
1.0
279.30
291.98
mg/l
0.45
63
52
89
109
8.79
68.39
1.2
1.2
348.26
247.02
u/ml
1.71
61
59
90
112
8.66
68.27
9.8
5.1
761.56
469.60
iu/ml
0.31
34
15
627
3397
2.94
67.52
4.6
2.3
—
—
—
0
0
91
120
8.17
65.79
1.2
1.2
—
—
—
0
0
91
121
8.10
65.32
1.3
1.3
—
23.32
—
0
5
60
45
14.04
64.32
1.2
1.0
—
—
—
0
0
289
1099
3.20
57.58
7.2
5.1
1.06
1.03
mmol/l
0.84
274
1001
693
4193
2.74
56.58
14.2
5.9
3.99
4.51
e9/l
6.86
628
3594
653
4057
2.48
46.96
10.4
5.5
1.19
1.21
mmol/l
8.66
565
3432
720
4710
2.50
45.71
12.9
3.0
198.07
54.55
u/l
43.83
696
4256
213
780
3.14
44.28
8.6
6.4
1.79
1.54
mmol/l
1.56
207
757
47
46
10.62
42.45
1.2
1.2
—
—
—
0
0
269
1165
2.73
40.85
1.8
1.2
4.49
2.94
g/l
13.66
230
652
153
479
3.54
40.84
10.5
9.1
—
—
—
0
0
597
3715
2.31
40.63
9.7
5.2
1.18
1.20
mmol/l
7.03
576
3299
167
556
3.36
40.46
10.7
8.9
94.63
93.41
%
1.93
167
551
102
241
4.56
40.20
1.9
1.7
—
—
—
0
0
731
4998
2.35
39.21
12.2
4.6
7.81
6.95
mmol/l
12.83
710
4687
252
1094
2.69
37.80
9.4
6.7
12.62
11.12
kpa
5.72
243
1034
252
1094
2.69
37.80
9.4
6.7
4.97
5.09
kpa
1.18
243
1037
412
2282
2.28
35.93
4.1
3.0
1.06
0.45
e6/l
1.98
329
1742
247
1093
2.62
35.44
9.4
6.7
0.16
1.32
mmol/l
5.13
206
855
280
1321
2.50
35.09
3.3
2.8
1.26
1.36
e6/l
0.13
163
745
213
885
2.74
34.58
10.4
7.4
117.57
123.05
g/l
3.14
208
864
564
3593
2.16
34.20
8.3
5.4
24.00
25.79
%
3.00
536
3307
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
110
311
3.82
33.98
2.7
2.7
0.25
0.34
u/ml
2.97
55
181
220
946
2.65
33.28
4.0
3.2
5.49
5.87
kpa
5.36
215
903
435
2530
2.18
33.03
4.3
3.0
69.24
86.87
e6/l
0.23
348
1961
813
6027
2.30
32.94
26.6
5.2
149.22
77.70
u/l
53.35
793
5535
287
1408
2.40
32.74
3.2
2.6
0.86
0.97
e6/l
0.37
170
826
218
942
2.64
32.60
4.1
3.2
0.76
2.04
mmol/l
5.06
172
775
552
3562
2.09
31.52
8.0
5.3
59.84
58.66
%
1.31
525
3283
475
2950
2.07
29.54
3.9
2.7
170.99
157.65
ug/l
0.52
445
2661
42
60
7.24
28.13
1.0
1.0
—
—
—
0
0
33
35
9.69
28.06
3.3
2.4
46293.94
39577.14
ug/l
1.64
33
35
32
34
9.66
27.17
1.9
1.3
—
—
—
0
0
38
16
24.54
27.13
1.1
1.1
—
—
—
0
0
162
666
2.68
26.45
3.8
2.3
67.59
61.14
ml/min/173m2
0.84
74
257
457
2886
1.99
26.33
4.9
3.4
80.05
112.78
e6/l
0.59
362
2091
194
876
2.47
26.05
4.1
3.3
—
—
—
0
0
407
2475
2.02
26.05
5.9
2.0
2.32
2.34
mmol/l
2.13
380
2020
372
2193
2.05
25.94
3.0
2.2
3.80
2.92
mg/l
6.79
329
1821
471
3041
1.95
25.14
4.3
3.0
—
—
—
0
0
29
33
9.00
23.37
1.7
1.3
—
—
—
0
0
138
562
2.66
22.83
1.8
1.5
—
—
—
0
0
264
1468
2.05
20.96
6.1
2.1
2.50
2.44
mmol/l
9.30
246
1227
463
3113
1.84
20.70
4.4
3.9
13.51
7.70
mg/mmol
1.79
329
2079
299
1751
1.97
20.45
3.5
2.3
4.98
3.70
e6/l
1.29
282
1562
45
98
4.74
19.52
1.1
1.2
—
—
—
0
0
262
1496
1.98
19.11
2.0
1.8
—
—
—
0
0
443
2993
1.80
19.08
3.7
3.2
7.13
7.98
mmol/l
4.00
369
2508
670
5208
1.72
16.77
5.3
4.2
542.75
2532.37
e6/l
0.93
12
95
429
2959
1.73
16.62
3.7
3.3
465.60
159.12
mg/l
0.73
317
1998
196
1069
2.01
16.04
2.0
1.8
—
—
—
0
0
134
633
2.27
15.89
4.4
3.1
1.21
1.22
mmol/l
0.44
126
537
92
366
2.65
15.84
2.0
1.7
1.88
1.98
ug/l
0.06
85
317
204
1141
1.97
15.50
2.7
1.9
1.96
1.75
%
1.99
183
984
195
1074
1.99
15.49
2.0
1.8
—
—
—
0
0
342
2297
1.71
14.10
4.1
2.6
3487.62
7490.05
umol/l
0.95
303
1948
17
7
24.62
12.48
1.2
1.0
—
—
—
0
0
248
1570
1.75
12.45
1.9
1.6
2.84
1.34
mg/l
3.78
210
1216
94
429
2.30
12.04
1.7
1.6
1.16
1.48
g/l
2.63
78
360
55
193
2.95
12.00
1.2
1.4
307.79
289.66
ug/g
0.23
28
116
135
735
1.95
10.92
2.7
1.5
66.54
66.71
g/l
0.08
122
652
107
539
2.09
10.74
1.5
1.5
—
—
—
0
0
20
38
5.34
10.14
1.6
1.4
1.73
7.11
u/l
2.06
15
33
108
564
2.01
9.83
1.7
1.7
—
—
—
0
0
32
91
3.59
9.82
2.9
2.8
1.96
1.15
%
0.44
25
75
13
6
21.90
9.36
6.0
1.3
55.15
41.33
u/l
—
13
6
113
612
1.94
9.27
3.1
1.7
397.30
370.64
nmol/l
0.66
105
546
311
4156
0.65
9.20
3.7
3.8
23.35
24.28
%
0.39
133
2045
116
638
1.91
9.09
8.6
7.0
23.29
24.62
mmol/l
2.55
111
607
66
293
2.33
9.04
2.2
2.2
196.83
101.15
ug/min
0.58
47
183
203
1329
1.65
8.73
1.2
1.2
1.53
1.72
u/ml
0.17
41
353
50
199
2.58
8.66
1.5
1.5
—
—
—
0
0
396
3020
1.48
8.59
2.9
3.1
1320.21
1793.60
ng/l
0.93
350
2609
62
278
2.30
8.32
2.4
1.4
34.87
36.59
mg/l
0.17
49
226
62
279
2.29
8.25
2.4
1.4
48.56
47.44
mg/l
0.07
49
227
153
943
1.72
8.24
2.9
3.2
219.48
266.69
ng/l
0.85
142
880
27
80
3.43
7.83
1.2
1.2
—
—
—
0
0
18
29
6.29
7.25
1.8
1.4
—
—
—
0
0
10
7
14.40
6.40
1.0
1.0
—
—
—
0
0
718
7964
0.72
6.05
5.8
5.0
6.84
6.16
mmol/l
19.71
649
7118
40
171
2.39
6.04
1.7
1.5
—
—
—
0
0
44
197
2.28
5.99
3.2
2.4
14.96
16.53
%
1.43
20
110
255
1895
1.45
5.97
4.0
4.2
410.29
501.91
ng/l
0.23
227
1655
34
137
2.53
5.82
1.3
1.4
7.85
6.43
u/l
0.54
22
113
213
2863
0.68
5.79
2.6
2.7
0.82
0.74
ug/l
0.69
142
2001
736
8109
0.73
5.72
6.3
5.5
2.30
2.54
mmol/l
11.26
672
7364
712
7875
0.73
5.58
6.0
4.8
4.02
4.34
mmol/l
13.98
656
7197
58
303
1.96
5.35
2.6
1.4
0.90
0.41
g/l
0.53
46
257
53
269
2.02
5.30
2.7
1.4
0.12
0.02
g/l
0.56
44
245
707
7800
0.74
5.19
5.9
4.8
1.21
1.36
mmol/l
19.17
644
7068
50
251
2.04
5.16
2.8
1.4
0.00
0.00
g/l
-0.00
41
228
362
2934
1.35
4.94
3.0
2.2
73.38
76.74
nmol/l
1.22
327
2516
28
113
2.52
4.82
2.8
3.1
54.86
60.02
%
1.41
28
113
8
7
11.50
4.79
1.5
1.0
—
—
—
0
0
48
247
1.99
4.65
2.9
1.4
0.00
0.00
g/l
-0.00
40
227
62
351
1.81
4.52
4.9
4.4
2.05
1.48
mmol/l
0.97
62
344
27
111
2.47
4.49
2.7
2.9
3.44
4.89
e9/l
2.80
27
111
249
1930
1.37
4.47
1.8
1.8
1135.35
1156.63
nmol/l
0.13
185
1453
441
5136
0.77
4.46
4.4
3.9
2.04
2.11
ug/l
0.13
370
4580
36
171
2.14
4.32
1.4
1.6
—
—
—
0
0
95
613
1.60
4.31
3.5
3.7
89.94
95.45
ng/l
0.30
87
518
28
120
2.37
4.27
1.6
1.5
—
—
—
0
0
48
255
1.92
4.27
1.3
1.2
—
—
—
0
0
23
90
2.59
4.23
1.7
2.4
851.27
659.24
ml
1.24
15
59
689
7550
0.77
4.20
5.4
4.3
1.41
1.30
mmol/l
3.01
626
6775
27
116
2.36
4.11
2.1
1.5
1571.91
1542.50
e6/l
0.01
22
78
59
342
1.77
4.01
2.8
1.4
2.97
3.01
g/l
0.13
50
295
103
693
1.54
3.92
3.0
2.2
192.90
171.76
ug/g
0.24
80
537
21
82
2.59
3.90
1.8
1.6
—
—
—
0
0
18
65
2.80
3.86
3.1
3.0
51.17
58.72
%
0.52
12
52
52
294
1.81
3.84
2.8
1.4
36.58
36.97
g/l
0.18
43
247
33
161
2.08
3.74
1.6
1.5
—
—
—
0
0
25
109
2.32
3.70
2.0
1.5
32751.28
94985.59
e6/l
0.54
18
64
439
3772
1.27
3.65
2.2
2.1
83.14
91.33
pmol/l
3.35
219
2021
94
632
1.53
3.60
3.1
3.7
4.92
5.19
kpa
2.29
84
593
61
369
1.69
3.59
2.8
1.4
7.42
7.48
g/l
0.11
52
321
14
46
3.07
3.53
1.0
1.0
—
—
—
0
0
419
3594
1.27
3.49
4.6
4.1
31.02
74.09
ng/l
2.42
357
2775
13
37
3.54
3.41
1.3
1.3
—
—
—
0
0
446
3865
1.26
3.38
4.4
3.5
0.01
0.01
estimate
0.15
105
720
35
182
1.95
3.36
1.1
1.4
0.65
0.81
nmol/l
1.16
25
153
442
3828
1.26
3.36
5.8
4.7
0.00
0.00
estimate
-0.00
97
659
88
593
1.53
3.35
3.1
3.6
1.44
1.90
mmol/l
0.50
55
431
60
369
1.66
3.34
2.8
1.4
4.27
3.76
g/l
1.90
52
322
60
369
1.66
3.34
2.8
1.4
—
—
—
0
0
13
38
3.45
3.31
1.3
1.3
—
—
—
0
0
27
129
2.12
3.26
1.8
2.1
107.04
105.57
mmol/l
0.87
27
129
27
129
2.12
3.26
1.8
2.1
4.28
4.12
mmol/l
0.92
27
129
16
60
2.69
3.23
1.8
1.5
—
—
—
0
0
18
72
2.52
3.22
2.5
2.2
—
—
—
0
0
40
223
1.82
3.14
1.6
1.4
—
—
—
0
0
40
223
1.82
3.14
1.6
1.4
—
—
—
0
0
33
173
1.94
3.12
1.6
1.4
—
—
—
0
0
48
284
1.72
3.10
1.5
1.7
53.30
38.83
u/l
2.39
38
232
56
349
1.64
2.99
2.6
1.4
12.97
10.76
g/l
2.27
46
301
8
17
4.73
2.92
1.5
1.2
—
—
—
0
0
17
70
2.45
2.89
1.0
1.1
—
—
—
0
0
443
3895
1.23
2.81
4.4
3.5
0.00
0.00
estimate
0.50
84
637
243
2018
1.26
2.56
1.9
1.7
446.31
16150989.75
pmol/l
1.27
200
1647
70
479
1.49
2.53
3.3
2.4
0.52
0.30
e6/l
0.41
70
471
11
37
2.99
2.49
1.7
1.5
—
—
—
0
0
9
26
3.48
2.48
3.4
2.0
—
—
—
0
0
8
21
3.83
2.46
1.4
1.2
11.24
8.93
ug/l
—
8
21
14
57
2.47
2.45
1.5
1.8
12.28
14.63
umol/l
0.68
14
50
11
38
2.91
2.41
1.7
1.5
—
—
—
0
0
78
1080
0.70
2.40
1.2
1.2
20.83
41.75
iu/ml
3.02
29
320
22
411
0.53
2.39
1.5
1.9
—
—
—
0
0
47
300
1.59
2.34
2.0
3.0
—
—
—
0
0
26
140
1.88
2.33
1.3
1.2
—
—
—
0
0
12
47
2.57
2.27
1.1
1.4
—
—
—
0
0
12
47
2.57
2.27
1.1
1.4
—
—
—
0
0
833
7894
1.22
2.20
36.8
14.5
31.26
27.28
mg/l
2.76
799
6215
251
2129
1.23
2.18
4.8
3.7
0.00
0.00
estimate
0.50
85
621
74
1015
0.71
2.17
1.2
1.2
22.19
14.04
u/ml
0.30
25
365
8
25
3.22
2.09
1.0
1.0
1675.38
1478.08
miu/ml
—
8
25
5
10
5.02
2.07
1.2
3.8
—
—
—
0
0
11
44
2.52
2.01
1.7
1.4
—
—
—
0
0
20
104
1.94
2.01
1.8
1.4
—
—
—
0
0
840
8769
0.83
1.96
53.9
20.9
125.20
137.29
g/l
65.53
816
8540
840
8768
0.83
1.95
53.4
20.8
4.19
4.51
e12/l
44.23
805
8387
11
45
2.46
1.93
1.2
1.3
19.16
20.97
iu/l
—
5
36
840
8765
0.83
1.92
53.4
20.8
190.15
232.70
e9/l
37.24
807
8428
18
92
1.97
1.90
1.2
1.2
1.50
2.45
u/ml
—
8
31
729
7699
0.85
1.90
10.3
6.6
45.29
41.34
mmol/mol
12.97
673
7044
840
8761
0.83
1.88
54.2
20.9
37.61
40.38
%
27.56
759
7948
15
72
2.10
1.87
1.3
1.2
—
—
—
0
0
12
54
2.24
1.74
2.3
1.5
—
—
—
0
0
7
24
2.93
1.72
1.3
1.8
37.66
62.32
ug/l
—
7
24
17
91
1.88
1.61
1.4
1.2
2.08
6.89
u/ml
1.37
12
46
14
70
2.01
1.59
1.3
1.2
—
—
—
0
0
20
114
1.77
1.57
2.2
2.5
12.67
19.07
mg/l
—
6
29
14
71
1.98
1.54
1.3
1.2
—
—
—
0
0
14
71
1.98
1.54
1.3
1.2
—
—
—
0
0
14
71
1.98
1.54
1.3
1.2
—
—
—
0
0
625
5866
1.15
1.52
5.3
3.9
22.49
12.68
mm/h
22.69
573
5327
7
27
2.60
1.51
1.6
1.4
—
—
—
0
0
7
27
2.60
1.51
1.6
1.4
—
—
—
0
0
14
72
1.96
1.49
1.3
1.2
—
—
—
0
0
186
2157
0.83
1.47
2.2
1.6
1.62
1.35
mmol/l
3.24
171
1761
40
279
1.45
1.42
3.4
3.0
4.22
4.45
pmol/l
0.73
35
240
329
2966
1.16
1.40
4.7
3.7
—
—
—
0
0
17
96
1.78
1.39
1.5
1.4
—
—
—
0
0
7
29
2.42
1.39
1.0
1.2
—
—
—
0
0
18
299
0.60
1.39
1.8
1.3
—
—
—
0
0
251
2218
1.17
1.38
1.8
1.6
16.90
19.45
nmol/l
2.65
221
1861
13
68
1.92
1.33
2.4
2.3
—
—
—
0
0
5
18
2.79
1.28
1.2
1.1
—
—
—
0
0
5
18
2.79
1.28
1.2
1.1
—
—
—
0
0
5
18
2.79
1.28
1.2
1.1
—
—
—
0
0
119
993
1.22
1.25
2.6
2.5
6.17
7.98
ug/l
0.57
98
867
20
123
1.64
1.24
1.6
1.3
—
—
—
0
0
49
365
1.36
1.23
1.7
1.6
—
—
—
0
0
18
108
1.68
1.22
1.5
1.4
—
—
—
0
0
680
7121
0.88
1.22
4.8
4.1
2.43
2.04
mu/l
3.83
613
6326
88
719
1.24
1.14
1.3
1.3
—
—
—
0
0
14
80
1.76
1.13
1.3
1.3
—
—
—
0
0
7
31
2.27
1.10
3.7
2.7
—
—
—
0
0
314
2867
1.13
1.09
2.0
2.2
197.43
269.92
u/l
0.92
298
2660
20
128
1.57
1.09
10.8
8.1
9.05
7.61
mmol/l
0.85
15
108
18
114
1.59
1.03
1.3
1.4
—
—
—
0
0
18
114
1.59
1.03
1.3
1.4
—
—
—
0
0
48
371
1.31
0.98
2.9
4.1
23.52
24.78
mmol/l
2.13
42
339
44
336
1.32
0.98
1.6
1.5
—
—
—
0
0
692
6643
1.11
0.95
47.9
16.6
15.71
15.26
%
1.84
683
6468
9
51
1.77
0.94
1.4
1.1
—
—
—
0
0
12
70
1.72
0.92
1.5
2.0
1.80
0.82
u/field
—
5
22
822
8454
0.89
0.90
31.3
9.1
42.43
26.53
u/l
41.65
806
8030
40
306
1.32
0.90
1.2
1.2
28.01
109.53
iu/ml
—
10
115
29
213
1.37
0.85
1.2
1.2
—
—
—
0
0
13
80
1.63
0.84
1.2
1.2
—
—
—
0
0
29
215
1.36
0.81
1.2
1.2
—
—
—
0
0
19
270
0.70
0.79
1.4
1.6
—
—
—
0
0
96
1110
0.85
0.78
4.4
4.9
31.54
32.29
%
0.30
74
730
6
34
1.77
0.76
1.5
1.5
230.50
205.76
u/l
—
6
34
29
220
1.33
0.72
2.6
2.1
119.29
133.91
g/l
2.68
24
166
7
40
1.75
0.71
1.3
1.2
—
—
—
0
0
13
85
1.54
0.69
1.3
1.4
—
—
—
0
0
13
85
1.54
0.69
1.3
1.4
—
—
—
0
0
5
27
1.86
0.68
1.4
1.2
—
—
—
0
0
14
94
1.50
0.67
1.2
1.2
1.79
0.63
nmol/l
0.53
14
88
13
86
1.52
0.66
1.2
1.1
103.77
110.99
%
0.28
13
77
834
8523
0.91
0.64
44.3
17.9
4.04
4.02
mmol/l
0.86
811
8245
13
87
1.50
0.63
1.0
1.3
471.38
270.66
pmol/l
0.45
13
73
5
30
1.67
0.61
1.2
1.1
—
—
—
0
0
5
30
1.67
0.61
1.2
1.1
—
—
—
0
0
833
8505
0.92
0.60
44.1
17.8
138.11
139.77
mmol/l
46.27
813
8233
13
185
0.70
0.58
1.9
1.5
—
—
—
0
0
7
114
0.61
0.58
1.3
1.0
—
—
—
0
0
537
5570
0.93
0.58
4.1
3.3
14.68
15.06
pmol/l
2.99
478
4927
8
54
1.48
0.57
1.0
1.1
—
—
—
0
0
8
54
1.48
0.57
1.0
1.1
—
—
—
0
0
26
204
1.28
0.54
3.3
3.1
30.62
32.75
mg/l
0.14
21
141
14
99
1.42
0.54
1.8
1.3
—
—
—
0
0
18
238
0.75
0.53
1.4
1.6
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
6
40
1.50
0.51
1.0
1.2
—
—
—
0
0
8
56
1.43
0.42
1.0
1.1
—
—
—
0
0
8
56
1.43
0.42
1.0
1.1
—
—
—
0
0
8
56
1.43
0.42
1.0
1.1
—
—
—
0
0
6
95
0.63
0.42
1.5
1.3
16344.17
266927.26
e6/l
—
6
69
0
15
0.00
0.41
0.0
1.1
—
15.40
—
0
9
0
15
0.00
0.41
0.0
1.0
—
—
—
0
0
358
3725
0.94
0.40
2.5
2.3
—
—
—
0
0
5
35
1.43
0.39
1.0
1.1
—
—
—
0
0
21
169
1.25
0.39
1.5
1.1
52.13
21.29
u/l
0.71
21
149
32
271
1.19
0.37
1.3
1.2
—
—
—
0
0
13
98
1.33
0.37
1.7
1.6
—
—
—
0
0
14
179
0.78
0.35
1.3
1.3
0.89
48.45
e6/l
—
9
146
12
91
1.32
0.34
1.2
1.1
—
—
—
0
0
20
242
0.82
0.33
1.4
1.6
22492.00
17520.30
e6/l
0.18
14
178
111
1186
0.93
0.29
15.1
7.1
—
—
—
0
0
30
261
1.15
0.28
1.3
1.4
—
—
—
0
0
22
257
0.85
0.26
1.1
1.0
—
—
—
0
0
9
73
1.23
0.25
1.3
1.3
—
—
—
0
0
733
7428
0.96
0.24
36.1
13.5
76.40
74.22
ml/min/173m2
1.69
659
6013
5
38
1.32
0.23
1.8
1.1
791.60
228.73
iu/ml
—
5
38
22
190
1.16
0.23
1.6
2.0
227.09
217.36
pmol/l
0.14
22
179
73
680
1.08
0.22
2.5
2.2
13.38
15.05
nmol/l
0.60
60
589
5
40
1.25
0.22
1.0
1.1
—
—
—
0
0
0
11
0.00
0.21
0.0
1.5
—
—
—
0
0
0
11
0.00
0.21
0.0
2.5
—
—
—
0
0
0
11
0.00
0.21
0.0
1.3
—
16.06
—
0
5
0
10
0.00
0.21
0.0
2.6
—
—
—
0
0
0
12
0.00
0.21
0.0
1.3
—
—
—
0
0
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
0
13
0.00
0.21
0.0
1.1
—
—
—
0
0
0
13
0.00
0.21
0.0
1.1
—
—
—
0
0
0
14
0.00
0.20
0.0
1.0
—
—
—
0
0
17
147
1.16
0.18
1.3
1.4
—
—
—
0
0
7
62
1.13
0.17
1.1
1.2
—
—
—
0
0
7
62
1.13
0.17
1.1
1.2
—
—
—
0
0
7
62
1.13
0.17
1.1
1.2
—
—
—
0
0
6
79
0.76
0.15
1.3
1.5
164.33
172.64
pmol/l
—
6
79
9
78
1.16
0.15
1.3
1.3
—
—
—
0
0
15
134
1.12
0.11
1.5
1.1
—
—
—
0
0
177
1810
0.97
0.10
5.5
3.7
1.01
1.02
kg/l
1.85
37
283
11
96
1.15
0.10
3.9
4.3
—
—
—
0
0
5
45
1.11
0.10
1.2
1.0
—
—
—
0
0
5
45
1.11
0.10
1.2
1.0
—
—
—
0
0
9
86
1.05
0.07
1.0
1.0
—
—
—
0
0
20
190
1.05
0.04
1.6
1.7
—
—
—
0
0
21
201
1.05
0.03
1.3
1.5
3.33
0.14
iu/ml
—
6
51
22
224
0.98
0.00
1.1
1.7
—
—
—
0
0
15
155
0.97
0.00
1.0
1.1
—
—
—
0
0
12
125
0.96
0.00
1.4
1.2
—
38.81
—
0
11
0
5
0.00
-0.00
0.0
1.6
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.6
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.7
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.2
—
—
—
0
0
6
69
0.87
-0.00
1.0
1.4
—
58.00
—
0
5
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.6
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.7
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
24.48
—
0
6
0
8
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.3
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.4
—
0.92
—
0
5
0
7
0.00
-0.00
0.0
5.3
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.3
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
8
82
0.98
-0.00
1.0
1.2
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
7
74
0.95
-0.00
1.0
1.5
—
195.00
—
0
10
0
6
0.00
-0.00
0.0
1.8
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded (different definition than used in FinnGen).
Relationships between endpoints
↥Index endpoint: C3_HEPATOCELLU_CARC_WIDE – Hepatocellular carcinoma, including Hilmo
GWS hits: 3
This endpoint is excluded (different definition than used in FinnGen).